NASDAQ:TMCI

Treace Medical Concepts Stock Insider Trading

Healthcare > Medical - Devices

Buy TMCI

*Your capital is at risk

$4.31

-0.0700 (-1.60%)

At Close: Jul 31, 2026

Treace Medical Concepts Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 75.77. In total, the insiders bought 2.8M and sold 377.12K TMCI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	75.77
● Buy	2.8M shares
● Sell	377.12K shares
51% Buy Activity Moderate Positive Correlation
Buy Signal High Confidence Jun 10, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 75.77. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 20, 2025 Buy	Common Stock A-Award	Jain Deepti Director	Director	23 917 Value: $160.0K
May 08, 2025 Buy	Common Stock A-Award	Elder Scot Michael Chief Legl & Comp Off, Corpsec	Officer	7 775 Value: $58.6K
May 08, 2025 Sell	Common Stock F-InKind	Elder Scot Michael Chief Legl & Comp Off, Corpsec	Officer	1 894 Value: $14.3K
May 08, 2025 Sell	Common Stock F-InKind	Elder Scot Michael Chief Legl & Comp Off, Corpsec	Officer	1 894 Value: $14.3K
May 08, 2025 Buy	Common Stock A-Award	Elder Scot Michael Chief Legl & Comp Off, Corpsec	Officer	7 775 Value: $58.6K
Mar 17, 2025 Buy	Common Stock M-Exempt	Scanlan Sean F. Chief Innovation Officer	Officer	50 000 Value: $52.5K
Mar 17, 2025 Sell	Common Stock S-Sale	Scanlan Sean F. Chief Innovation Officer	Officer	50 000 Value: $398.5K
Mar 17, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Scanlan Sean F. Chief Innovation Officer	Officer	50 000 Value: $52.5K
Mar 17, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Scanlan Sean F. Chief Innovation Officer	Officer	50 000 Value: $52.5K
Mar 17, 2025 Sell	Common Stock S-Sale	Scanlan Sean F. Chief Innovation Officer	Officer	50 000 Value: $398.5K
Mar 17, 2025 Buy	Common Stock M-Exempt	Scanlan Sean F. Chief Innovation Officer	Officer	50 000 Value: $52.5K
Mar 10, 2025 Sell	Common Stock F-InKind	Berutti Aaron SVP, Sales	Officer	1 815 Value: $0
Mar 10, 2025 Sell	Common Stock F-InKind	Treace John T. Chief Executive Officer	CEO / President	5 021 Value: $0
Mar 10, 2025 Sell	Common Stock F-InKind	Scanlan Sean F. Chief Innovation Officer	Officer	1 396 Value: $0
Mar 10, 2025 Sell	Common Stock F-InKind	Elder Scot Michael Chief Legl & Comp Off, Corpsec	Officer	1 675 Value: $0
Mar 10, 2025 Sell	Common Stock F-InKind	Hair Mark Chief Financial Officer	C-Suite Officer	3 684 Value: $0
Mar 10, 2025 Sell	Common Stock F-InKind	Treace John T. Chief Executive Officer	CEO / President	5 021 Value: $0
Mar 10, 2025 Sell	Common Stock F-InKind	Berutti Aaron SVP, Sales	Officer	1 815 Value: $0
Mar 08, 2025 Sell	Common Stock F-InKind	Berutti Aaron SVP, Sales	Officer	728 Value: $0
Mar 08, 2025 Sell	Common Stock F-InKind	Treace John T. Chief Executive Officer	CEO / President	2 063 Value: $0
Mar 08, 2025 Sell	Common Stock F-InKind	Scanlan Sean F. Chief Innovation Officer	Officer	401 Value: $0
Mar 08, 2025 Sell	Common Stock F-InKind	Elder Scot Michael Chief Legl & Comp Off, Corpsec	Officer	176 Value: $0
Mar 08, 2025 Sell	Common Stock F-InKind	Hair Mark Chief Financial Officer	C-Suite Officer	961 Value: $0
Mar 08, 2025 Sell	Common Stock F-InKind	Scanlan Sean F. Chief Innovation Officer	Officer	401 Value: $0
Mar 08, 2025 Sell	Common Stock F-InKind	Treace John T. Chief Executive Officer	CEO / President	2 063 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT TREACE MEDICAL CONCEPTS, INC.

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers pro...

Read Full Profile Here